Loading
Latest filing published 14 Nov 2025 for Zomedica Corp., €13k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Russell Kevin Klass appears in our data through filings on Zomedica Corp. shares, published by SEC (Form 4). The record holds 16 filings, for trades running from 10 June 2024 to 13 November 2025.
No open-market sale appears; the market trades are 16 purchases worth €353k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Since January 2025: 11 purchases and no sales on the market.
The median purchase comes to €17k. 6 out of 16 purchases came within 30 days of a purchase by at least one other insider of the same company. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.
Most recently, on 14 November 2025, the filings show an open-market purchase worth €13k in Zomedica Corp. The median gap between a trade and its publication by SEC (Form 4) is 1 day. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 of 11 declarations